undamentalytics Newsletter

Goodrx Holdings vs Hinge Health

Goodrx Holdings is the larger business, with $797m of revenue in fiscal 2025 against $588m for Hinge Health (1.4 times as much). Hinge Health grew faster (50.6% against 0.6%). Goodrx Holdings kept more of each dollar of sales as profit: a net margin of 3.8% against -89.9%. Hinge Health carries less debt relative to equity (0.0% against 80.3%).

Latest fiscal yearGoodrx HoldingsGDRX, 2025Hinge HealthHNGE, 2025
Revenue $797m $588m
Revenue growth 0.6% 50.6%
Net income $30.4m −$528m
Operating margin 11.0% -92.9%
Net margin 3.8% -89.9%
Return on equity 4.5% —
Free cash flow $164m $171m
Cash $262m $208m
Total debt $495m $0
Debt to equity 80.3% 0.0%
Dividend per share — —
Dividend yield — —
Share buybacks $216m $65.0m
Employees 697 —
Market value $1.22bn $6.32bn
Price vs our value range Below our value range —
Moat score 28 (Weak) —
Insider trades, 12 months 0 buys, 14 sales 0 buys, 206 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.